ABCDEFGHIJKLMNOPQRSTUVWX
1
Table 1. Patient demgraphics and clinical characteristics
2
PatientsLung Cancer Dataset (n=124)Silver-Labeled Dataset (n=1832)Esophageal Cancer Dataset (n=75)
3
Age in Years (Mean, SD)68.6, 12.167.9, 14.670.8, 10.9
4
Gender
5
Male53 (42.7%)932 (50.8%)62 (82.7%)
6
Female71 (57.3%)900 ( 49.2%)13 (17.3%)
7
Race
8
White113 (91.1%)1607 (87.7%)70 (93.3%)
9
Asian6 (4.8%)70 (3.8%)1 (1.3%)
10
Black075 (4.1%)1 (1.3%)
11
Two or more08 (0.4%)0
12
Others031 (1.7%)3 (4.0%)
13
Not reported5 (4%)41 (2.2%)0
14
Ethnic Group
15
Non Hispanic118 (95.2%)1683 (91.8%)69 (92.0%)
16
Hispanic014 (0.8%)1 (1.3%)
17
Not reported6 (4.8%)135 ( 7.4%)5 (6.7%)
18
Disease Site
19
Lung Cancer
20
 Non-small cell lung cancer124 (100%)798 (43.6%)0
21
 Other Histology0126 (6.9%)0
22
Gastrointestinal Cancer
23
 Esophageal Cancer0167 (9.1%)75 (100%)
24
 Other Histology0129 (7.0%)0
25
Others0612 (33.4%)0
26
Concurrent Chemotherapy
27
Yes107 (86.3%)NA*71 (94.7%)
28
No17 (13.7%)NA*4 (5.3%)
29
Abbreviations: NA = not applicable
30
All data presented as N (%) unless otherwise notesd.
31
*Concurrent chemotherapy not available for the silver-labeled dataset.
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100